DRUG
Bright Minds Biosciences Inc.
Biotechnology · Healthcare · United States
54.98
close · 2026-10-30
value
99
cheaper than peers99
quality
97
stronger fundamentals97
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| cash flow yield, 1 year ago | -0.3% | 100 |
| cash flow yield, latest year | -1.6% | 97 |
| cash flow yield, 2 years ago | -1.3% | 96 |
| earnings yield, 1 year ago | -1.2% | 96 |
| earnings yield, 2 years ago | -3.6% | 95 |
| earnings yield, latest year | -3.2% | 91 |
| cash flow yield, 3 years ago | -2.5% | 79 |
| earnings yield, 3 years ago | -11.0% | 73 |
| price to book | 2.47× | 49 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 0.0% | 98 |
| return on equity | -15.0% | 96 |
| operating margin | 0.0% | 50 |
3 of 4 measures available
Facts
| market cap | $542M |
| free cash flow | -$13.1M |
| employees | 26 |
| first trade | 2021-03-22 |
| next earnings | not reported |
| fundamentals updated | 2026-07-28 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -1.78 | -0.65 | -1.98 | -6.06 |
| free cash flow | -$8.7M | -$1.9M | -$7.0M | -$13.6M |
| net income | -$12.2M | -$2.8M | -$7.4M | -$15.0M |
| revenue | $0 | $0 | $0 | $0 |
| unusual items | $188,768 | -$9,312 | $14,189 | $10,151 |